HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of RXFP1 in skin of scleroderma patients and control subjects.

AbstractOBJECTIVES:
Relaxin (RLX) is involved in extracellular matrix and collagen remodelling. The therapeutic role of the circulating isoform RLX-2 as an anti-fibrotic factor in systemic sclerosis (SSc) has been investigated. Several RLX family peptide receptors (RXFPs) are recognized in humans: RLX-2 is a ligand for RXFP1/LGR7 and RXFP2/LGR8. The aim of this study was to define the pattern of expression of LGR7 in different types of human skin cells and to compare normal skin with lesional and unaffected skin from patients with limited SSc (lSSc).
METHOD:
We analysed RXFP1 immunolocalization on skin biopsies and cultured fibroblasts from lSSc patients and control subjects. Western blot analysis was carried out on fibroblast lysates.
RESULTS:
RXFP1 showed cytoplasmic localization on skin cells from control subjects and non-lesional skin from lSSc patients: keratinocytes, gland epithelial cells, endothelium, smooth muscle cells, and fibroblasts. Immunogold electron microscopy confirmed a diffuse epithelial cytoplasmic localization of RXFP1. A substantially lower RXFP1 expression was observed in scleroderma skin, with a lack of staining in most cells. Occasional weak reactivity was observed in cultured scleroderma fibroblasts, while control fibroblasts showed a diffuse cytoplasmic immunoreactivity of RXFP1, confirmed by Western blot analysis.
CONCLUSIONS:
The decreased cellular expression of RLX-2 receptor RXFP1 in scleroderma skin might represent a pro-fibrotic factor and contribute to the substantial inefficacy of RLX treatment in SSc, as reported in the literature. The pathophysiology of the decrease in RXFP1 may be linked to high RLX-2 serum levels previously detected in SSc, but it has yet to be elucidated.
AuthorsN Giordano, N Volpi, D Franci, C Corallo, A Fioravanti, P Papakostas, A Montella, M Biagioli, M Fimiani, G Grasso, M M Muscettola, R Guerranti, D Vannoni, M Galeazzi, R Nuti
JournalScandinavian journal of rheumatology (Scand J Rheumatol) Vol. 41 Issue 5 Pg. 391-5 (Oct 2012) ISSN: 1502-7732 [Electronic] England
PMID23043266 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RXFP1 protein, human
  • Receptors, G-Protein-Coupled
  • Receptors, Peptide
Topics
  • Aged
  • Cells, Cultured
  • Female
  • Fibroblasts (metabolism, pathology)
  • Fibrosis (metabolism, pathology)
  • Humans
  • Middle Aged
  • Receptors, G-Protein-Coupled (metabolism)
  • Receptors, Peptide (metabolism)
  • Scleroderma, Systemic (metabolism, pathology)
  • Skin (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: